Ex vivo ATLAS-identification of neoantigens for personalized cancer immunotherapy in mouse melanoma

被引：0
|
作者：
Starobinets, Hanna [1 ]
Nogueira, Catarina [1 ]
Ferber, Kyle [1 ]
Xu, Huilei [1 ]
Dhaneshwar, Abha [2 ]
Dobson, Jason R. [1 ]
Loizeaux, James [1 ]
Foti, James [1 ]
O'Keefe, Michael [1 ]
Donis, Erick [1 ]
Broom, Wendy [1 ]
Carroll, Pamela [1 ]
Kirschmeier, Paul [2 ]
Flechtner, Jessica B. [1 ]
Lam, Hubert [1 ]
机构：
[1] Genocea Biosci, Cambridge, MA USA
[2] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5718
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5718
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Developing a personalized immunotherapy for lung cancer patients: Identification of tumor reactive CTLs
    Yoshikawa, Toshiaki
    Nosaka, Kazuto
    Suzuki, Toshihiro
    Saito, Keigo
    Shimomura, Manami
    Mizuno, Shoichi
    Suzuki, Yutaka
    Seki, Masahide
    Sakamoto, Hiromi
    Aoki, Kazunori
    Aokage, Keiju
    Tsuboi, Masahiro
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2018, 109 : 293 - 293
  • [42] Development of a personalized ex vivo drug screening test for patients with ovarian cancer.
    Brueckner, Luzi
    Reinshagen, Annika
    Aktas, Bahriye
    Bechmann, Ingo
    Nel, Ivonne
    Kallendrusch, Sonja
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Ex vivo CSC assays for personalized testing of drug susceptibility in advanced breast cancer
    Charafe-Jauffret, Emmanuelle
    Wicinski, Julien
    Cabaud, Olivier
    Lopez, Marc
    Audebert, Stephane
    Adelaide, Jose
    Chaffanet, Max
    Guille, Arnaud
    Goncalves, Anthony
    Bertucci, Francois
    Birnbaum, Daniel
    Ginestier, Christophe
    CANCER RESEARCH, 2018, 78 (04)
  • [44] Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non-Small Cell Lung Cancer
    Jia, Qingzhu
    Chiu, Luting
    Wu, Shuangxiu
    Bai, Jian
    Peng, Lina
    Zheng, Linpeng
    Zang, Rui
    Li, Xueqin
    Yuan, Bibo
    Gao, Yixing
    Wu, Dingyong
    Li, Xiaohong
    Wu, Lin
    Sun, Jianguo
    He, Ji
    Robinson, Bruce W. S.
    Zhu, Bo
    ADVANCED SCIENCE, 2020, 7 (09)
  • [45] Cancer Immunotherapy Is More Effective in Irradiated Tumors in Preclinical Mouse Model of Melanoma
    Wang, J.
    Li, L.
    Wagner, K. T.
    Zhao, Y.
    Zheng, J.
    Wang, A. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S123 - S123
  • [46] Exploring mRNA lipid nanoparticles for ex vivo T cell engineering in cancer immunotherapy
    Harinck, L.
    Umbach, A.
    De Munter, S.
    De Velder, M.
    Berdecka, D.
    Vandekerckhove, B.
    Cereseto, A.
    Braeckmans, K.
    Raemdonck, K.
    HUMAN GENE THERAPY, 2025, 36 (3-4) : E521 - E521
  • [47] Exploring mRNA lipid nanoparticles for ex vivo T cell engineering in cancer immunotherapy
    Harinck, L.
    Aernout, I.
    Berdecka, D.
    Braeckmans, K.
    Raemdonck, K.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A225 - A225
  • [48] STIMULATION OF TUMOR INFILTRATING B-CELLS IMPROVES EX-VIVO TIL EXPANSION FOR MELANOMA IMMUNOTHERAPY
    Rossetti, Renata
    Tordesillas, Leticia
    Beatty, Matthew
    Chen, Yian Ann
    Du, Dongliang
    Sarnaik, Amod
    Pilon-Thomas, Shari
    Abate-Daga, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A206 - A206
  • [49] Patient Derived Ex-Vivo Cancer Models in Drug Development, Personalized Medicine, and Radiotherapy
    Zitter, Ryan
    Chugh, Rishi Man
    Saha, Subhrajit
    CANCERS, 2022, 14 (12)
  • [50] Development and validation of personalized ex vivo platform mimicking patient heterogeneous tumor microenvironment to enable personalized treatment for breast cancer
    Majumder, P. K.
    Majumder, B.
    Mehrotra, D. G.
    Radhakrishnan, P.
    Baraneedharan, U.
    Agarwal, S.
    Sengupta, S.
    Babu, G.
    CANCER RESEARCH, 2016, 76
12345